Holly Vedova, the top official in the US Federal Trade Commission’s (FTC) Bureau of Competition, is set to retire after more than three decades at the agency, reported Bloomberg.
Vedova has been a driving force behind some of the FTC’s most high-profile antitrust cases in recent years. She has been the bureau’s Acting Director since January 2017 and was responsible for leading the FTC’s litigation against Qualcomm in a lawsuit that accused the company of violating antitrust law.
Related: Former FTC Litigator Peter Herrick Moves To O’Melveny
Holly Vedova is the Director of the Bureau of Competition. Holly served as former FTC Commissioner Rohit Chopra’s chief attorney advisor on competition, and has served as attorney advisor to four commissioners since joining the FTC in 1990. In this role, Holly helped draft countless Commission statements, opinions, and speeches, and has played a key role in many of the agency’s policy-making processes. Holly started her career at the FTC right out of law school as an attorney in one of BC’s merger shops, and has also served as Counsel to the BC Director.
Vedova’s departure will give FTC Chair Lina Khan an opportunity to appoint a new bureau director. It is not yet clear who Khan will appoint to replace Vedova.
Featured News
College Sports Leaders in Intensive Talks to Settle NIL Antitrust Case Against NCAA
Apr 30, 2024 by
CPI
EU Investigates Facebook’s and Instagram’s Handling of Disinformation Ahead of Elections
Apr 30, 2024 by
CPI
Antitrust Lawsuit Targets Hotel Giants for Alleged Price Fixing with AI
Apr 30, 2024 by
CPI
ABA Seeks to Join FTC Lawsuit Against Amazon Over Antitrust Concerns
Apr 30, 2024 by
CPI
Google Agrees to Pay News Corp for AI-Related Content
Apr 30, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI